Identification of ESM-1 as a new endothelial biomarker in the pathogenesis of rheumatoid arthritis
The aim of this study was to investigate the use of ESM-1 (endothelial cell-specific molecule-1) as a new biomarker for the pathogenesis of rheumatoid arthritis (RA). The study cohort was divided into four groups according to the DAS28 disease activity score: 16 patients were classified as being in...
Main Authors: | Gönül Gürol Ciftci, Ihsan Hakkı Ciftci, Engin Karakece, Halil Harman, Ayhan Kamanlı, Ibrahim Tekeoglu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-05-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13102818.2016.1148635 |
Similar Items
-
Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea
by: Haili Sun, et al.
Published: (2019-08-01) -
Increase of endocan, a new marker for inflammation and endothelial dysfunction, in acute kidney injury
by: Murat Gunay, et al.
Published: (2019-06-01) -
Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance
by: Nannan Kang, et al.
Published: (2022-11-01) -
Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease
by: Hee-Jeong Hong, et al.
Published: (2022-07-01) -
Identification of ESM1 overexpressed in head and neck squamous cell carcinoma
by: Hongbo Xu, et al.
Published: (2019-05-01)